Bill > HB5553

This bill authorizes the Public Employees Insurance Agency (PEIA) and the Department of Human Services to participate in federal prescription drug pricing programs, which are arrangements established by the federal government to potentially lower the cost of prescription drugs, possibly by using models like "most-favored-nation" pricing (meaning the U.S. would get prices similar to what other developed countries pay) or international reference pricing. This participation could involve direct purchasing agreements with drug manufacturers, joining federally negotiated pricing deals, or using federal price benchmarks for reimbursements, but only if it's financially beneficial to the state and doesn't limit people's access to necessary medications. The bill clarifies that this participation doesn't force the state to adopt federal drug lists or interfere with its own pharmacy benefit administration, and both agencies must report annually to the Joint Committee on Government and Finance about their participation, cost savings, and any issues encountered.

Health and Social Services

http://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=5553&year=2026&sessiontype=RS&btype=bill